Angela Di Paola

Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial

Sandra A. Springer, Angela Di Paola, Marwan M. Azar et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 99 citations

Medicine, Pharmacology, Pharmacotherapy +16

Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial

Sandra A. Springer, Angela Di Paola, Russell Barbour et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +17

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

Angela Di Paola, Thomas Lincoln, Daniel J. Skiest et al. · Contemporary Clinical Trials · 2014 · 36 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community

Sandra A. Springer, Angela Di Paola, Marwan M. Azar et al. · Drug and Alcohol Dependence · 2017 · 35 citations

Public Health, Pharmacology, Pharmacotherapy +14

A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of ‘Getting to Zero’ initiatives

Aditya Khanna, John A. Schneider, Nicholson Collier et al. · AIDS · 2019 · 35 citations · Full text

Public Health, Health Policy, Infectious Disease Control +17